Literature DB >> 19247622

[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis].

D Knüttgen1, M Kamp, M Ströhlein, J Matten, A Chemaissani, K Ernestus, S G Sakka, F Wappler.   

Abstract

Invasive pulmonary aspergillosis (IPA) is a life-threatening infection predominantly affecting immunocompromised patients, e.g. with acute leukemia. This case report demonstrates that IPA can also occur in non-neutropenic critically ill surgical patients. The case of a 63-year-old woman is reported, who developed IPA of the respiratory tract in the course of diffuse purulent peritonitis. First-line therapy with voriconazol failed to be effective. However, application of caspofungin, intensive kinetic therapy (including prone position) and airway management by interventional bronchoscopy enabled successful treatment of this severe complication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19247622     DOI: 10.1007/s00101-008-1496-6

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  13 in total

1.  Septic mice are susceptible to pulmonary aspergillosis.

Authors:  Claudia F Benjamim; Cory M Hogaboam; Nicholas W Lukacs; Steven L Kunkel
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 2.  Risk factors for nosocomial infection in intensive care. 'Devices vs nature' and goals for the next decade.

Authors:  D G Maki
Journal:  Arch Intern Med       Date:  1989-01

3.  Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

Authors:  Johan Maertens; Issam Raad; George Petrikkos; Marc Boogaerts; Dominik Selleslag; Finn B Petersen; Carole A Sable; Nicholas A Kartsonis; Angela Ngai; Arlene Taylor; Thomas F Patterson; David W Denning; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2004-11-09       Impact factor: 9.079

4.  Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.

Authors:  E Castagnola; L Moresco; B Cappelli; D Cuzzubbo; C Moroni; E Lanino; M Faraci
Journal:  J Chemother       Date:  2007-06       Impact factor: 1.714

5.  Nontraumatic disruption of the fibrocartilaginous trachea: causes and clinical outcomes.

Authors:  Michelle R Aerni; Joseph G Parambil; Mark S Allen; James P Utz
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

6.  Calcification in invasive tracheal aspergillosis demonstrated on ultrasound: a new finding.

Authors:  A E Drury; R A Allan; H Underhill; S Ball; A E Joseph
Journal:  Br J Radiol       Date:  2001-10       Impact factor: 3.039

7.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

8.  Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis.

Authors:  T T Ng; G D Robson; D W Denning
Journal:  Microbiology (Reading)       Date:  1994-09       Impact factor: 2.777

Review 9.  Adrenal corticosteroid biosynthesis, metabolism, and action.

Authors:  Wiebke Arlt; Paul M Stewart
Journal:  Endocrinol Metab Clin North Am       Date:  2005-06       Impact factor: 4.741

Review 10.  Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients.

Authors:  R J Trof; A Beishuizen; Y J Debets-Ossenkopp; A R J Girbes; A B J Groeneveld
Journal:  Intensive Care Med       Date:  2007-07-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.